Total Drugs
10
0G / 10B
Avg Price / Unit
$695.4773
$55.03 – $1719.46
Avg 7d Change
0.00%
Across 0 drugs with changes
7d Activity
of 10 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
VIVITROL 380 MG VIAL-DILUENT naltrexone | $1719.4648 per EA | — |
ARISTADA INITIO ER 675 MG/2.4 aripiprazole lauroxil | $1026.9112 per ML | — |
ARISTADA ER 662 MG/2.4 ML SYRN aripiprazole lauroxil | $1000.6931 per ML | — |
ARISTADA ER 882 MG/3.2 ML SYRN aripiprazole lauroxil | $999.6811 per ML | — |
ARISTADA ER 441 MG/1.6 ML SYRN aripiprazole lauroxil | $999.5820 per ML | — |
ARISTADA ER 1,064 MG/3.9 ML SYR aripiprazole lauroxil | $988.0564 per ML | — |
LYBALVI 10-10 MG TABLET olanzapine and samidorphan L-malate | $55.1356 per EA | — |
LYBALVI 5-10 MG TABLET olanzapine and samidorphan L-malate | $55.1279 per EA | — |
LYBALVI 15-10 MG TABLET olanzapine and samidorphan L-malate | $55.0894 per EA | — |
LYBALVI 20-10 MG TABLET olanzapine and samidorphan L-malate | $55.0315 per EA | — |
FDA Recalls (3)
Recalls matched by company name. Verify current status with FDA.
Vivitrol (naltrexone for extended-release injectable suspension) 380 mg/vial. Each Carton Contains: 1) One vial of 380 mg of Vivitrol, 2) One vial containing 4 mL of diluent, 3) One 5-mL prepackaged syringe, 4) One 20-gauge 1-inch needle, 5) Two 20-gauge 1.5-inch safety needles, 6) Two 20-gauge 2-inch safety needles. Rx Only. Manufactured and marketed by: Alkermes, Inc. Kit NDC: 65757-300-01
Labeling: Not Elsewhere Classified. Drug product kit recalled due to 1 inch needles being placed in the 1 1/2 inch needle cardboard sleeve labelled as administration needles. The product vial is not impacted.
VIVITROL (naltrexone for extended-release injectable suspension); 380 mg vial NDC 65757-300-01; RX Only Manufactured and marketed by Alkermes, Inc., Waltham, MA 02451.
Customer complaints for failure to deliver the dose.
VIVITROL (naltrexone for extended-release injectable suspension) a) 380 mg vial NDC 65757-303-02, b) 380 mg vial in kit NDC 65757-300-01, Rx Only Manufactured and marketed by Alkermes, Inc., Waltham, MA 02451,
Lack of Assurance of Sterility: Product did not meet the criteria for container closure integrity testing during routine 24 month stability testing.